Extrawell Pharmaceutical Holdings Limited (HKG:0858)

HKG:0858 Cash Flow Statement

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	-162.95	129.27	130.59	-121.1
Depreciation & Amortization	-	9.05	8.8	8.73	8.12
Loss (Gain) From Sale of Assets	-	-	-	0.06	-
Loss (Gain) From Sale of Investments	-	132.93	-158.66	-168.64	104.7
Loss (Gain) on Equity Investments	-	2.28	3.85	3.65	2.88
Provision & Write-off of Bad Debts	-	0.09	0.8	-0.27	-2.73
Other Operating Activities	-	17.99	13.74	19.59	6.19
Change in Accounts Receivable	-	1.37	1	3.19	0.82
Change in Inventory	-	-4.13	4.89	-0.63	-1.63
Change in Accounts Payable	-	-1.83	0.18	-0.24	0.45
Change in Other Net Operating Assets	-	-2.97	-3.53	-0.14	1.44
Operating Cash Flow	-	-3.69	1.18	-1.77	-0.85
Capital Expenditures	-	-1.2	-6.62	-9.63	-0.72
Investment in Securities	-	-	-5.88	-	-
Other Investing Activities	-	3.24	4.06	0.25	0.68
Investing Cash Flow	-	2.04	-8.44	-9.38	-0.04
Long-Term Debt Repaid	-	-1.32	-2.3	-1.8	-1.69
Net Debt Issued (Repaid)	-	-1.32	-2.3	-1.8	-1.69
Other Financing Activities	-	-5.18	-0.09	-0.14	-0.21
Financing Cash Flow	-	-6.5	-2.39	-1.94	-1.9
Foreign Exchange Rate Adjustments	-	-0.64	0.16	-1.75	3.07
Net Cash Flow	-	-8.79	-9.48	-14.83	0.27
Free Cash Flow	-	-4.89	-5.44	-11.39	-1.57
Free Cash Flow Margin	-	-8.28%	-7.49%	-15.41%	-2.00%
Free Cash Flow Per Share	-	-0.00	-0.00	-0.00	-0.00
Cash Interest Paid	-	0.29	0.09	0.14	0.21
Cash Income Tax Paid	-	0.07	0.38	0.06	0.04
Levered Free Cash Flow	-	-22.38	-14.71	-9.53	-8.67
Unlevered Free Cash Flow	-	-10.63	-4.94	-1.26	-1.64
Change in Net Working Capital	-13.45	14.37	0.07	-7.73	2.25

Updated Dec 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.